RIL
YMAB

Rothschild Investment LLC’s Y-mAbs Therapeutics YMAB Stock Holding History

Rothschild Investment LLC’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50
Closed -$226 – 3262
2025
Q2 		$226 Sell
50
-60
-55% -$270 ﹤0.01% 2920
2025
Q1 		$487 Buy
110
+70
+175% +$406 ﹤0.01% 2628
2024
Q4 		$313 Buy
40
+15
+60% +$183 ﹤0.01% 2680
2024
Q3 		$329 Buy
+25
New +$317 ﹤0.01% 2588

Other funds holding YMAB

BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rothschild Investment LLC's YMAB Position: Q3 2025 in Review

Rothschild Investment LLC sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 50 shares — an estimated $226 sold.

Rothschild Investment LLC first reported a position in YMAB in Q3 2024 and held it in 4 quarters. The position peaked at $487 in Q1 2025. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

  • Rothschild Investment LLC reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Rothschild Investment LLC sold 50 Y-mAbs Therapeutics shares in Q3 2025, an estimated $226.
  • Rothschild Investment LLC first reported a position in Y-mAbs Therapeutics in Q3 2024 and held it in 4 quarters.
  • Rothschild Investment LLC's Y-mAbs Therapeutics position peaked at $487 in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on Rothschild Investment LLC's 13F filing for Q3 2025, filed 7 Nov 2025.